EUVIMEDEUVIMED entdecken
Open Access

Monoallelic de novo AJAP1 loss-of-function variants disrupt trans-synaptic control of neurotransmitter release

Simon Früh iD, Sami Boudkkazi, Peter Koppensteiner iD, Vita Sereikaite, Li-Yuan Chen iD, Diego Fernandez-Fernandez iD, Pascal D Rem iD, Daniel Ulrich, Jochen Schwenk iD, Ziyang Chen, Elodie Le Monnier iD, Thorsten Fritzius iD und 26 weitere

Science Advances · 12.07.2024 · 10 (28)

DOI: 10.1126/sciadv.adk5462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 12.07.2024. Verfasst von Simon Früh und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland. Hauptthemen laut MEDLINE: Neurotransmitter Agents, Synapses, Synaptic Transmission. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adherens junction–associated protein 1 (AJAP1) has been implicated in brain diseases; however, a pathogenic mechanism has not been identified. AJAP1 is widely expressed in neurons and binds to γ-aminobutyric acid type B receptors (GBRs), which inhibit neurotransmitter release at most synapses in the brain. Here, we show that AJAP1 is selectively expressed in dendrites and trans-synaptically recruits GBRs to presynaptic sites of neurons expressing AJAP1. We have identified several monoallelic AJAP1 variants in individuals with epilepsy and/or neurodevelopmental disorders. Specifically, we show that the variant p.(W183C) lacks binding to GBRs, resulting in the inability to recruit them. Ultrastructural analysis revealed significantly decreased presynaptic GBR levels in Ajap1 −/− and Ajap1 W183C/+ mice. Consequently, these mice exhibited reduced GBR-mediated presynaptic inhibition at excitatory and inhibitory synapses, along with impaired synaptic plasticity. Our study reveals that AJAP1 enables the postsynaptic neuron to regulate the level of presynaptic GBR-mediated inhibition, supporting the clinical relevance of loss-of-function AJAP1 variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurotransmitter AgentsSynapsesSynaptic TransmissionAnimalsFemaleHumansMaleMiceAllelesEpilepsyLoss of Function MutationMice, KnockoutNeurodevelopmental DisordersNeuronal PlasticityNeuronsCell Adhesion Molecules

Substanzen

Neurotransmitter AgentsAJAP1 protein, humanCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
  • Institute of Physiology II, University of Freiburg, Hermann-Herderstrasse 7, 79104 Freiburg, Germany.
  • Institute of Science and Technology Austria (IST Austria), Klosterneuburg, Austria.
  • Center for Biopharmaceuticals, Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.
  • Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 7, 1005 Lausanne, Switzerland.
  • Biocenter, University of Basel, Spitalstrasse 41, 4056 Basel, Switzerland.

ORCID-Profile: Simon Früh, Peter Koppensteiner, Li-Yuan Chen, Diego Fernandez-Fernandez, Pascal D Rem, Jochen Schwenk, Elodie Le Monnier, Thorsten Fritzius, Luca Trovò, Michal Stawarski, Emanuela Argilli, Elliott H Sherr, Erik-Jan Kamsteeg, Maria Iascone, Alba Pilotta, Maria R Cutrì, Mahshid S Azamian, Jill A Rosenfeld, Xiaonan Zhao, Tiphanie P Vogel, Daryl A Scott, Peter Scheiffele, Kristian Strømgaard, Mehdi Tafti, Martin Gassmann, Bernd Fakler, Ryuichi Shigemoto, Bernhard Bettler

Zitieren

APA

Früh, S., Boudkkazi, S., Koppensteiner, P., Sereikaite, V., Chen, L. Y., Fernandez-Fernandez, D., Rem, P. D., Ulrich, D., Schwenk, J., Chen, Z., Le Monnier, E., Fritzius, T., Innocenti, S. M., Besseyrias, V., Trovò, L., Stawarski, M., Argilli, E., Sherr, E. H., van Bon, B., …, & Bettler, B. (2024). Monoallelic de novo AJAP1 loss-of-function variants disrupt trans-synaptic control of neurotransmitter release. Science Advances, 10(28). https://doi.org/10.1126/sciadv.adk5462

Vancouver

Früh S, Boudkkazi S, Koppensteiner P, Sereikaite V, Chen LY, Fernandez-Fernandez D, et al. Monoallelic de novo AJAP1 loss-of-function variants disrupt trans-synaptic control of neurotransmitter release. Science Advances. 2024;10(28). doi:10.1126/sciadv.adk5462

BibTeX
@article{Frh2024,
  author = {Früh, Simon and Boudkkazi, Sami and Koppensteiner, Peter and Sereikaite, Vita and Chen, Li-Yuan and Fernandez-Fernandez, Diego and Rem, Pascal D and Ulrich, Daniel and Schwenk, Jochen and Chen, Ziyang and Le Monnier, Elodie and Fritzius, Thorsten and Innocenti, Sabrina M and Besseyrias, Valérie and Trovò, Luca and Stawarski, Michal and Argilli, Emanuela and Sherr, Elliott H and van Bon, Bregje and Kamsteeg, Erik-Jan and Iascone, Maria and Pilotta, Alba and Cutrì, Maria R and Azamian, Mahshid S and Hernández-García, Andrés and Lalani, Seema R and Rosenfeld, Jill A and Zhao, Xiaonan and Vogel, Tiphanie P and Ona, Herda and Scott, Daryl A and Scheiffele, Peter and Strømgaard, Kristian and Tafti, Mehdi and Gassmann, Martin and Fakler, Bernd and Shigemoto, Ryuichi and Bettler, Bernhard},
  title = {Monoallelic de novo AJAP1 loss-of-function variants disrupt trans-synaptic control of neurotransmitter release},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {28},
  doi = {10.1126/sciadv.adk5462}
}
Kostenlos starten →